Maternus-Kliniken Aktiengesellschaft (FRA:MAK)

FRA:MAK Statistics

Total Valuation

FRA:MAK has a market cap or net worth of EUR 23.28 million. The enterprise value is 22.64 million.

Market Cap	23.28M
Enterprise Value	22.64M

Important Dates

The next estimated earnings date is Wednesday, December 17, 2025.

Earnings Date	Dec 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.97M
Shares Outstanding	n/a
Shares Change (YoY)	+2.36%
Shares Change (QoQ)	-1.91%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.20
PB Ratio	-0.35
P/TBV Ratio	n/a
P/FCF Ratio	2.38
P/OCF Ratio	2.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.76, with an EV/FCF ratio of 2.31.

EV / Earnings	-1.69
EV / Sales	0.19
EV / EBITDA	2.76
EV / EBIT	n/a
EV / FCF	2.31

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.63%
Return on Invested Capital (ROIC)	-81.57%
Return on Capital Employed (ROCE)	-6.64%
Revenue Per Employee	73,018
Profits Per Employee	-8,432
Employee Count	1,426
Asset Turnover	0.81
Inventory Turnover	185.04

Taxes

In the past 12 months, FRA:MAK has paid 3.22 million in taxes.

Income Tax	3.22M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.90%
50-Day Moving Average	1.11
200-Day Moving Average	1.31
Relative Strength Index (RSI)	48.11
Average Volume (20 Days)	450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MAK had revenue of EUR 116.17 million and -13.42 million in losses. Loss per share was -0.63.

Revenue	116.17M
Gross Profit	24.21M
Operating Income	-3.76M
Pretax Income	-10.31M
Net Income	-13.42M
EBITDA	-1.13M
EBIT	-3.76M
Loss Per Share	-0.63

Balance Sheet

The company has 2.18 million in cash and n/a in debt, giving a net cash position of 2.18 million.

Cash & Cash Equivalents	2.18M
Total Debt	n/a
Net Cash	2.18M
Net Cash Per Share	n/a
Equity (Book Value)	-67.40M
Book Value Per Share	-3.29
Working Capital	-62.96M

Cash Flow

In the last 12 months, operating cash flow was 9.89 million and capital expenditures -95,000, giving a free cash flow of 9.80 million.

Operating Cash Flow	9.89M
Capital Expenditures	-95,000
Free Cash Flow	9.80M
FCF Per Share	n/a

Margins

Gross margin is 20.84%, with operating and profit margins of -3.24% and -11.55%.

Gross Margin	20.84%
Operating Margin	-3.24%
Pretax Margin	-8.87%
Profit Margin	-11.55%
EBITDA Margin	-0.97%
EBIT Margin	-3.24%
FCF Margin	8.43%

Dividends & Yields

FRA:MAK does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.36%
Shareholder Yield	-2.36%
Earnings Yield	-57.63%
FCF Yield	42.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 1, 1996. It was a forward split with a ratio of 20.

Last Split Date	Oct 1, 1996
Split Type	Forward
Split Ratio	20

Scores

FRA:MAK has an Altman Z-Score of -0.96 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.96
Piotroski F-Score	5